Background Many genes are candidates for involvement in epileptic encephalopathy (EE) because one or a few possibly pathogenic variants have been found in patients, but insufficient genetic or functional evidence exists for a definite annotation. Methods To increase the number of validated EE genes, we sequenced 26 known and 351 candidate genes for EE in 360 patients. Variants in 25 genes known to be involved in EE or related phenotypes were followed up in 41 patients. We pri- oritized the candidate genes, and followed up 31 variants in this prioritized subset of candidate genes. Results Twenty-nine genotypes in known genes for EE (19) or related diseases (10), dominant as well as recessive or X-linked, were classified as likely pathogenic ...
The fulltext of this publication will be made publicly available after relevant embargo periods have...
Trio exome sequencing has been successful in identifying genes with de novo mutations (DNMs) causing...
OBJECTIVE: To evaluate the performance of an in silico prioritization approach that was applied to 1...
Many genes are candidates for involvement in epileptic encephalopathy (EE) because one or a few poss...
BACKGROUND: Exome sequencing has led to the discovery of mutations in novel causative genes for epil...
BACKGROUND:Early-onset epileptic encephalopathies are severe disorders in which seizure recurrence i...
WOS: 000394999100016PubMed ID: 27734276We investigated the genetic background of early-onset epilept...
Trio exome sequencing has been successful in identifying genes with de novo mutations (DNMs) causing...
PURPOSE: The management of epilepsy in children is particularly challenging when seizures are resist...
Massively parallel sequencing has revealed many de novo mutations in the etiology of developmental a...
Background: Childhood epilepsies are caused by heterogeneous underlying disorders where approximat...
Early-onset epileptic encephalopathy (EE) and combined developmental and epileptic encephalopathies ...
In order to characterize the genetic architecture of epilepsy in a pediatric population from the Ibe...
The fulltext of this publication will be made publicly available after relevant embargo periods have...
Trio exome sequencing has been successful in identifying genes with de novo mutations (DNMs) causing...
OBJECTIVE: To evaluate the performance of an in silico prioritization approach that was applied to 1...
Many genes are candidates for involvement in epileptic encephalopathy (EE) because one or a few poss...
BACKGROUND: Exome sequencing has led to the discovery of mutations in novel causative genes for epil...
BACKGROUND:Early-onset epileptic encephalopathies are severe disorders in which seizure recurrence i...
WOS: 000394999100016PubMed ID: 27734276We investigated the genetic background of early-onset epilept...
Trio exome sequencing has been successful in identifying genes with de novo mutations (DNMs) causing...
PURPOSE: The management of epilepsy in children is particularly challenging when seizures are resist...
Massively parallel sequencing has revealed many de novo mutations in the etiology of developmental a...
Background: Childhood epilepsies are caused by heterogeneous underlying disorders where approximat...
Early-onset epileptic encephalopathy (EE) and combined developmental and epileptic encephalopathies ...
In order to characterize the genetic architecture of epilepsy in a pediatric population from the Ibe...
The fulltext of this publication will be made publicly available after relevant embargo periods have...
Trio exome sequencing has been successful in identifying genes with de novo mutations (DNMs) causing...
OBJECTIVE: To evaluate the performance of an in silico prioritization approach that was applied to 1...